CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- 4 Shares withheld for taxes 10% owner gave up 1 shares (to pay taxes)
- 4 Open-market sale President and CEO sold 2,915 shares at an average $13.19 ($38,437)
- 4 Open-market sale Chief Accounting Officer sold 1,804 shares at an average $13.19 ($23,788)
- 4 Open-market sale President and CEO sold 2,958 shares at an average $11.62 ($34,360)
- 4 Open-market sale Chief Accounting Officer sold 1,809 shares at an average $11.61 ($21,009)
- 4 Open-market buy 10% owner bought 55,000 shares at $12.19 ($670,423)
- 4 Open-market buy 10% owner bought 19,335 shares at $9.64 ($186,372)
- 4 Grant or award Director acquired 7,828 shares (grant or award)
- 4 Grant or award Director acquired 7,828 shares (grant or award)
- 4 Grant or award Director acquired 7,828 shares (grant or award)
- 4 Grant or award Director acquired 7,828 shares (grant or award)
- 4 Grant or award Director acquired 7,828 shares (grant or award)
- 4 Grant or award Director acquired 7,828 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Accounting Officer sold 2,218 shares at $6.76 ($15,000)
- 4 Open-market sale President and CEO sold 3,276 shares at $6.76 ($22,156)
- 4 Grant or award Director acquired 75,572 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 2 of 33 · 644 filings